Specialist Care, Research and National Leadership in Inflammatory Breast Cancer
Inflammatory Breast Cancer (IBC) is a rare but aggressive form of breast cancer. Unlike many breast cancers, it does not usually present as a distinct lump. Instead, cancer cells block the lymphatic channels within the skin of the breast, leading to rapid changes in the appearance of the breast.
Common symptoms of inflammatory breast cancer include:
• Redness affecting part or all of the breast
• Swelling of the breast
• Warmth of the skin
• Thickened skin or a "peau d'orange" (orange peel) appearance
• Tenderness or discomfort
• Flattening or inversion of the nipple
• Rapid enlargement of the breast over days or weeks
Because these symptoms can resemble an infection such as mastitis, inflammatory breast cancer can sometimes be difficult to recognise. Prompt assessment by a breast specialist is essential, as early diagnosis and treatment can improve outcomes.
Inflammatory breast cancer usually requires treatment with a combination of chemotherapy, surgery and radiotherapy, with newer targeted treatments increasingly playing an important role for selected patients.
A National Interest in Inflammatory Breast Cancer
Mr Naren Basu has developed a national and international reputation for his work in inflammatory breast cancer, combining specialist clinical care with academic research aimed at improving diagnosis, treatment and outcomes for patients with this rare disease.
He is Associate Professor in Cancer Genomics at the University of Birmingham, where his research focuses on improving our understanding of breast cancer biology and translating scientific discoveries into better patient care.
Establishing the UK's First Dedicated Inflammatory Breast Cancer Clinic
Recognising the unique challenges faced by patients with inflammatory breast cancer, Mr Basu was part of the multidisciplinary team that established the United Kingdom's first dedicated Inflammatory Breast Cancer Clinic in 2022.
The clinic was created to bring together specialists with expertise in inflammatory breast cancer, ensuring patients have access to coordinated, evidence-based care and opportunities to participate in research where appropriate.
By concentrating specialist expertise within one service, the clinic also supports education, collaboration and innovation in this uncommon but complex disease.
Improving Care Across the UK
Mr Basu is committed to improving inflammatory breast cancer care nationally.
He is currently leading work to establish a National Inflammatory Breast Cancer Registry, which will collect high-quality clinical data from across the UK. The registry aims to improve understanding of inflammatory breast cancer, identify patterns of care and outcomes, and provide an important foundation for future clinical research.
Alongside this work, he is collaborating with the Association of Breast Surgery to help develop national guidance for the diagnosis, investigation and management of inflammatory breast cancer. The goal is to support consistent, evidence-based care for patients throughout the UK.
Research and International Collaboration
Research is central to Mr Basu's work.
He has presented his research on inflammatory breast cancer at national and international scientific meetings, sharing new knowledge and collaborating with specialists from around the world to advance understanding of this challenging disease.
He has also supervised medical students, postgraduate researchers and academic trainees undertaking projects in inflammatory breast cancer, helping to develop future clinicians and researchers with an interest in breast cancer care.
Current research includes the development of new studies investigating the biology of inflammatory breast cancer and evaluating novel therapies that may improve outcomes for patients diagnosed with this aggressive form of breast cancer.
Combining Research with Patient Care
Mr Basu believes that patients benefit when clinical care and research work together.
By combining specialist breast surgery with academic research, participation in national initiatives and international collaboration, he is committed to improving both current treatment and future outcomes for patients with inflammatory breast cancer.
His aim is not only to provide the highest standard of individual patient care but also to contribute to advances that will benefit patients diagnosed with inflammatory breast cancer for years to come.
Why This Matters for Patients
Inflammatory breast cancer is uncommon, and many patients will never have heard of it before receiving a diagnosis. Access to a clinician with experience in managing this condition can be invaluable.
Mr Basu's clinical practice, academic leadership and ongoing research ensure that his patients benefit from care informed by the latest evidence, delivered within a specialist multidisciplinary team, and supported by a commitment to advancing knowledge through research and collaboration.
If you have been diagnosed with inflammatory breast cancer, or have symptoms that are causing concern, early assessment by a breast specialist is important. Mr Basu provides expert, compassionate care, ensuring that every patient receives an individualised treatment plan based on the best available evidence.